Dublin, Jan. 22, 2019 (GLOBE NEWSWIRE) -- The "Liquid Biopsy Market (by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type, Regional & Country Wise Analysis), Initiatives, Funding and 20 Company Profile - Global Forecast to 2026" company profile has been added to ResearchAndMarkets.com's offering.
The global liquid biopsy market is expected to reach nearly US$ 6.5 Billion by 2026
Liquid biopsy is a non-invasive technology that detects molecular biomarkers using liquid sample without the need for costly or invasive procedures.
The abilities of liquid biopsy like, easy and minimal invasiveness, early cancer diagnosis & detection, characterization of new lesions, drug & therapeutic target identifications for cancer treatment are some advantages of liquid biopsies, which improve the safety and efficiency of cancer therapy for patients.
The advantages of liquid biopsy over solid tumor biopsy, rising prevalence of cancer, increasing preference for non-invasive procedures, growing public and private funding to support research activities in the field of liquid biopsy and favorable government initiatives, are some of the factors expected to propel the growth of liquid biopsy market in the coming years.
Some of the key factors inhibiting the growth of liquid biopsy market includes, clinical utility challenges, lack of sensitivity and specificity of liquid biopsy tests and unclear reimbursement & regulation scenario.
Market Dynamics
Driving Factors
Challenges
Scope of the Report
Global Liquid Biopsy Market & Forecast - by Circulating Biomarker
Global Liquid Biopsy Market & Forecast - by Product
Global Liquid Biopsy Market & Forecast - by Application
Global Liquid Biopsy Oncology Market & Forecast - by Clinical Application
Global Liquid Biopsy Market & Forecast - by End User
Global Liquid Biopsy Market & Forecast - by Sample Type
Liquid Biopsy Market & Forecast - Regional Analysis
Global Liquid Biopsy Market & Forecast - by Circulating Biomarker (2015 - 2026)
1. Circulating Tumor Cells (CTCs)
2. Circulating Tumor DNA (ctDNA)
3. Cell-Free DNA (cfDNA)
4. Extracellular Vesicles (EVs)
5. Other Circulating Biomarkers
Global Liquid Biopsy Market & Forecast - by Product (2015 - 2026)
1. Kits and Consumables
2. Instruments
3. Services
Global Liquid Biopsy Market & Forecast - by Application (2015 - 2026)
1. Oncology Application
2. Non-Cancer Application
Global Liquid Biopsy Oncology Market & Forecast - by Clinical Application (2015 - 2026)
Global Liquid Biopsy Market & Forecast - by End User (2015 - 2026)
Global Liquid Biopsy Market & Forecast - by Sample Type (2015 - 2026)
Liquid Biopsy Market - Company Profiles
1. Personal Genome Diagnostics
2. Guardant Health, Inc.
3. Pathway Genomics
4. RainDance Technologies (Acquired by Bio-Rad Laboratories, Inc.)
5. Trovagene, Inc
6. Cynvenio Biosystems, Inc.
7. Biocept, Inc.
8. ANGLE plc
9. MDxHealth
10. Clearbridge BioMedics Pte Ltd
11. Exosome Diagnostics, Inc
12. Foundation Medicine, Inc
13. Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche AG)
14. Genomic Health
15. Myriad Genetics, Inc
16. Thermo Fisher Scientific, Inc
17. QIAGEN NV
18. Bio-Rad Laboratories, Inc
19. Menarini-Silicon Biosystems
20. GRAIL
For more information about this company profile visit https://www.researchandmarkets.com/research/zf76rp/global_liquid?w=12
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.